Back to search

Article

Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancer

2023-02-08

Abstract excerpt

Brachyury is a transcription factor belonging to the T-box gene family and is involved in the posterior formation of the mesoderm and differentiation of chordates. As the overexpression of Brachyury is a poor prognostic factor in a variety of cancers, the establishment of Brachyury-targeted therapy would be beneficial for the treatment of aggressive tumors. Because transcription factors are difficult to treat with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1be98980-13e4-5049-8c12-8efc6c4bddf3
DOI
10.21203/rs.3.rs-2553923/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 10 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Brachyury-targeted immunotherapy combined with gemcitabine against head and neck cancerDOI 10.21203/rs.3.rs-2553923/v1
Select a neighboring publication to make it the new centre.